瑞典卡罗林斯卡医学院招聘人类免疫系统微生物群研究博士后

2015-04-16 11:10 来源: 未知 作者: liuxuehr

Postdoctoral studies in human immune systemmicrobiota : Stockholm, Sweden

Research group and project
The research group at CIM is headed by Tim Willinger and studies the human immune system in vivo
using cutting-edge humanized mouse models (Nat Biotechnol 32:364, 2014). We are using geneticallymodified
mice and mice with a human immune system to investigate immune responses in mucosal
tissues (gut and lung) and the interaction of the immune system with commensal microbes (microbiota)
in health and disease.
Duties
1. Generation of mice with a human immune system
2. Functional analysis of mucosal immune system
3. Systems biology analyses using next-generation sequencing
The successful candidate is expected to play a critical role in formulating scientific research hypotheses,
testing the hypotheses using proper study design, analyzing the data, presenting and interpreting the
results, and writing scientific reports and articles in English.
Qualifications
To qualify, the applicant must have a PhD in Immunology or equivalent with publications in
internationally renowned peer-reviewed journals. Merit is given to applicants who are experienced in
multicolor flow cytometry and functional immunological assays. Great advantage is experience in
designing and performing animal experiments and previous work with genetically-modified mice.
The candidate should be highly motivated, have good communication skills, and ability to interact
effectively and work productively in a team. Fluency in English is a requirement.
To be eligible, an applicant must hold a PhD (third cycle) degree.
Selection is made of qualified applicants on the ground of their ability to benefit from doctoral (third
cycle) education. Karolinska Institutet applies the following assessment criteria:
-Documented subject knowledge of significance to the research project
-Analytical skills confirmed by a scientific dissertation or the equivalent

https://ki.mynetworkglobal.com/en/what:job/jobID:62886/where:4/

声明:凡本网注明"来源:XXX"的文/图等稿件,本网转载出于传递更多信息及方便产业探讨之目的,并不意味着本站赞同其观点或证实其内容的真实性,文章内容仅供参考。如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任。作者如果不希望被转载或者联系转载等事宜,请与我们联系。

微信公众号